The future of gene editing with Intellia’s CEO
Intellia Therapeutics CEO John Leonard on where he sees gene editing fitting into the practice of medicine.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square